Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
lingering cough; voice problems (hoarseness); fever; lethargy; no appetite; 11 lb weight loss; This is a spontaneous report received from an Other HCP, Program ID. A 62-year-old female patient received rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), in Dec2024 as dose 1, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COUGH (non-serious), 2 days after the suspect product(s) administration, outcome "unknown", described as "lingering cough"; DYSPHONIA (non-serious), 2 days after the suspect product(s) administration, outcome "unknown", described as "voice problems (hoarseness)"; PYREXIA (non-serious), 2 days after the suspect product(s) administration, outcome "unknown", described as "fever"; LETHARGY (non-serious), 2 days after the suspect product(s) administration, outcome "unknown"; DECREASED APPETITE (non-serious), 2 days after the suspect product(s) administration, outcome "unknown", described as "no appetite"; WEIGHT DECREASED (non-serious), 2 days after the suspect product(s) administration, outcome "unknown", described as "11 lb weight loss". Relevant laboratory tests and procedures are available in the appropriate section.
Test Name: WEIGHT; Result Unstructured Data: Test Result:11 lb weight loss